Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | AMGN | VRTX | BMY | GILD |
| Company | Genmab A/S ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 21.94 | 306.00 | 491.34 | 59.21 | 94.13 |
| High | 22.20 | 307.43 | 498.25 | 59.49 | 94.21 |
| Low | 21.59 | 298.91 | 491.03 | 57.84 | 91.63 |
| Last | 21.66 | 301.44 | 494.61 | 58.41 | 92.63 |
| Change | -0.81 | +2.60 | +4.61 | -0.61 | -1.72 |
| % Change | -3.60% | +0.87% | +0.94% | -1.03% | -1.82% |
| Volume | 2,583,700 | 3,725,500 | 1,079,400 | 11,214,900 | 11,060,400 |
| 20-Day Average Volume | 1,483,755 | 2,229,915 | 1,169,430 | 10,662,150 | 6,775,645 |
| Previous Close | 22.47 | 298.84 | 490.00 | 59.02 | 94.35 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.76 | 317.12 | 484.76 | 54.49 | 90.36 |
| 20-Day Raw Stochastic | 3.72% | 22.17% | 55.46% | 71.20% | 52.86% |
| 20-Day Relative Strength | 33.49% | 36.48% | 54.74% | 64.16% | 61.48% |
| Weighted Alpha | -36.38 | +7.94 | +35.79 | +24.86 | +32.15 |
| Today's Opinion | 100% Sell | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 56% Buy | 48% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.00% since 11/06/24 | -6.32% since 11/06/24 | +0.20% since 11/06/24 | +5.66% since 11/06/24 | +1.03% since 11/06/24 |
| Low | 21.59 on 11/13/24 | 293.80 on 11/12/24 | 486.64 on 11/07/24 | 53.97 on 11/08/24 | 91.63 on 11/13/24 |
| High | 23.47 on 11/11/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | -7.95% since 10/11/24 | -8.20% since 10/11/24 | +2.68% since 10/11/24 | +11.90% since 10/11/24 | +9.04% since 10/11/24 |
| Low | 21.59 on 11/13/24 | 293.80 on 11/12/24 | 463.14 on 11/01/24 | 51.31 on 10/15/24 | 84.34 on 10/14/24 |
| High | 23.67 on 10/14/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -18.48% since 08/13/24 | -6.80% since 08/13/24 | +5.78% since 08/13/24 | +19.06% since 08/13/24 | +25.21% since 08/13/24 |
| Low | 21.59 on 11/13/24 | 293.80 on 11/12/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 27.94 on 08/27/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -25.72% since 05/13/24 | -2.27% since 05/13/24 | +15.04% since 05/13/24 | +29.63% since 05/13/24 | +37.15% since 05/13/24 |
| Low | 21.59 on 11/13/24 | 293.80 on 11/12/24 | 422.44 on 05/14/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 30.41 on 05/15/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,869,926 | 160,636,368 | 126,189,208 | 119,703,008 | 117,464,992 |
| Shares Outstanding, K | 661,768 | 537,533 | 257,529 | 2,028,177 | 1,244,992 |
| Annual Sales | 2,392,030,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | 631,910,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 816,600,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | 186,610,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.99 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.29 on 11/06/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 22.52 | 16.74 | 0.00 | 51.13 | 21.90 |